Specifically, the study highlights the discovery of SLC46A3, a solute carrier (SLC) transporter localized to the lysosome, as a negative regulator of liposomal NP uptake, which could influence NP accumulation and delivery in cancer cells. This evidence concerns the gene SLC46A3 and cancer.